Improving Cancer Pain Management Through Self-Care
This trial is active, not recruiting.
|Treatment||pro-self plus pain management program|
|Sponsor||University of California, San Francisco|
|Start date||December 2007|
|End date||December 2012|
|Trial size||222 participants|
|Trial identifier||NCT00708019, Cancer Pain Management, R01 CA116423|
This study will test two different doses of a psychoeducational intervention to improve cancer pain management. In addition, the study will determine if the changes in pain management behaviors that the patients and family caregivers learn continue to be used when the intervention stops. It is hypothesized that patients and family caregivers who receive the high dose intervention will have a greater decrease in pain intensity scores.
|United States||No locations recruiting|
|Other Countries||No locations recruiting|
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
|Primary purpose||supportive care|
average pain intensity score
time frame: 10 weeks
worst pain intensity score
time frame: 10 weeks
Male or female participants at least 18 years old.
Inclusion Criteria: - adult oncology outpatients (> 18 years of age) - able to read, write, and understand English - agree to participate and give informed consent - have a KPS Score of > 50 - have an average pain intensity score of > 3.0 on a 0 to 10 NRS - have radiographic evidence of bone metastasis - visceral or somatic pain - have a life expectancy of at least 6 months - are receiving outpatient treatment for cancer (not AIDS-related) with any single or combination therapy, and have a telephone line Exclusion Criteria: - A documented previous or current psychiatric disorder or if at the time of recruitment they are receiving hospice care in order not to interfere with the pain management program provided by hospice.
|Official title||Improving Cancer Pain Management Through Self-Care|
|Principal investigator||Christine A. Miaskowski, RN, PhD|
|Description||Recent work from our research group demonstrated that the use of a 6-week psychoeducational intervention, called the PRO-SELF Pain Control Program, compared to standard care, resulted in clinically and statistically significant improvements in pain management in a sample of oncology outpatients with bone metastasis. While the overall effects of the intervention were significant, for approximately 70% of patients in the intervention group pain intensity scores did not decrease by > 30% and that worst pain intensity scores remained at or above 4 at the end of the intervention. Therefore, as a logical extension of this study, we propose a randomized clinical trial (RCT) that will test the effectiveness of two different doses of the revised PRO-SELF Pain Control Program [i.e., PRO-SELF PLUS-HIGH and PRO-SELF PLUS-LOW] on pain intensity and analgesic prescriptions. In addition, the sustainability of the two doses of the intervention will be evaluated. Adult oncology outpatients with pain from bone metastasis will be recruited, stratified by site and by whether or not they participate alone or with a family caregiver, and randomized to one of the doses of the intervention. The psychoeducational intervention will be conducted by specially trained oncology nurses and will include the components of knowledge, skills training, and coaching to improve cancer pain management. Patients in both groups will be seen in their homes over the course of 10 weeks with phone calls conducted in between the home visits. Patients in the HIGH-DOSE group will receive 6 visits and 10 phone calls [total time 12.3 hours]. Patients in the LOW-DOSE group will receive 4 visits and 6 phone calls [8.0 hours]. Follow-up visits to assess the sustainability of the intervention will be done at 2 weeks, 1 month and 3 months after the intervention. Both quantitative and qualitative analyses will be conducted to evaluate patient outcomes.|
Call for more information